Related Experiment Videos
Cytokine modulation for anti-allergic treatment
1Lung Pharmacology Group, Institute of Internal Medicine, Department of Respiratory Medicine and Allergology, Göteborg University, Gothenburg, Sweden. teet.pullerits@hjl.gu.se
Current Pharmaceutical Design
|August 13, 2002
Summary
Cytokines are key players in asthma pathogenesis. Modulating their effects offers targeted treatments beyond traditional glucocorticoids, with some cytokines showing therapeutic anti-inflammatory potential.
Area of Science:
- Immunology
- Pulmonology
- Allergy and Clinical Immunology
Background:
- Asthma pathogenesis involves complex airway inflammation driven by various cytokines.
- Current treatments, primarily systemic glucocorticoids, lack specificity.
- Cytokine modulation presents a promising alternative therapeutic strategy.
Purpose of the Study:
- To review the role of cytokines in allergic asthma pathogenesis.
- To discuss current knowledge on modulating cytokine effects for asthma treatment.
- To explore the therapeutic potential of anti-inflammatory cytokines.
Main Methods:
- Literature review of scientific articles and clinical studies.
- Analysis of cytokine involvement in asthma pathophysiology.
- Evaluation of therapeutic strategies targeting cytokine pathways.
Main Results:
- Cytokines significantly contribute to allergic asthma development and inflammation.
- Multiple pathways exist for cytokine modulation, including antibodies, receptor blockade, and gene transcription inhibition.
- Certain cytokines demonstrate anti-inflammatory properties, suggesting their use as therapeutic agents.
Conclusions:
- Targeting cytokines offers a more specific approach to asthma treatment compared to broad immunosuppression.
- Further research into cytokine modulation and anti-inflammatory cytokines is warranted for novel asthma therapies.